Catherine Warren

Executive Director

1 past transactions

Aptatek Biosciences

Seed Round in 2022
Aptatek Biosciences Inc is a Princeton, New Jersey-based company that develops portable disease management devices specifically for individuals with Phenylketonuria (PKU). Their innovative products utilize sensor technology to monitor phenylalanine levels in real-time, allowing for immediate blood analysis and reporting. These Bluetooth-enabled devices facilitate the detection of small molecules and biomarkers, enabling patients to make timely dietary adjustments to maintain their phenylalanine levels within clinical target ranges. By providing healthcare providers with tools to enhance patient compliance and overall wellness, Aptatek Biosciences aims to improve the quality of life for those affected by PKU.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.